Posted by Michael Wonder on 20 Jul 2018
FDA approves new indications for Zomacton (somatropin) as Ferring plans launch of needle-free delivery system
19 July 2018 - Ferring will launch ZOMA-Jet 10 needle-free delivery system for Zomacton in September.
Ferring Pharmaceuticals Inc. today announced that the U.S. FDA has approved Zomacton (somatropin) for injection in four additional paediatric indications:
- Idiopathic short stature
- Short stature associated with Turner syndrome
- Short stature born small for gestational age with no catch-up growth by 2 to 4 years
- Short stature or growth failure in short stature homeobox-containing gene deficiency
